Given the drama around the last two drugs approved for Alzheimer’s dementia, Aduhelm and Leqembi, we have a right to be skeptical.
Coverage of infectious and chronic diseases — their causes, mechanisms, epidemiology, prevention strategies, and the latest science on how the body fights back.
